Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 27 minutes ago 3 Views
Seeking Alpha / 27 minutes ago 3 Views
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting
Comments